Table 3.
Studies evaluating femoral vein tunneled cuffed catheter
| Study | Access | Patients, n | No. of Catheters/AVGs | Age, yr, Mean (Range) | Sex, N (Men) | Ethnicity (Black) | Diabetes, N | Follow-Up, d, Median (Range) | Median Primary Access Patency, d | Infection: All Episodes | Infection: Needing Catheter Removal | Infection: Rates (Episode per 1000 Catheter d) | Catheter Malfunction (Poor Flow) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Zaleski et al. 1999 (48) | FV-TCC | 21 | 41 | 52 (21–89) | 6 (28.6%) | NA | NA | 2506 | 61 | NA | 2.4 | 5.2 | 0 |
| Chow et al. 2001 (38) | FV-TCC | 11 | 14 | 55.2±9.4 | 9 (81.8%) | NA | 5 (45%) | 111 (0–605) | 166 | 9 | 5 | 3.8 | 3 |
| LE-AVG | 10 | 11 | 54.0±8.5 | 4 (40.0%) | 0 | 258 (2–919) | 560 | 8 | 2 | 2.3 | 1 | ||
| P=0.33 | P=0.05 | P=0.05 | P=0.33 | ||||||||||
| Maya and Allon 2005 (40) | FV-TCC | 27 | 27 | 52±13 | 11 (40.7%) | 24 (92.3%) | 9 (34.6%) | 1825 | 59 | NA | 6 (29%) | Approximately 4 | 15 (71%) |
| IJ-TCC | 54 | 54 | 55±12 | 22 (40.7%) | 40 (74.1%) | 25 (46.3%) | 1825 | >300 | NA | 2 (15%) | Approximately 4 | 11 (85%) | |
| P=0.25 | P>0.99 | P=0.06 | P=0.32 | ||||||||||
| Falk 2007 (39) | FV-TCC | 33 | 68 | 56 (29–78) | 14 (42.4%) | NA | NA | 51 | 51 | NA | 22 (32%) | 6.3 | 18 (27%) |
| Al-Hwiesh et al. 2007 (49) | FV-TCC | 14 | 14 | 49.8±5.9; 55 (21–68) | 9 (64.3%) | NA | 3 (21.4) | 137.5 | 182 | 4 (28.6%) | 0 | NA | 0 |
| Bertoli et al. 2010 (50) | FV-TCC | 25 | 25 | 77.7±10.8 (49–92) | 13 (52%) | NA | 7(28%) | 248 | NA | 11 | 3 | 1.77 | 0 |
| Burton et al. 2012 (41) | FV-TCC | 49 | 123 | 54.4 | 39 (31.7) | NA | 58 (17.2) | 38 | 96.3 (1–824) | 17 (13.8%) | 1.39 | 37 (30.1%) |
AVG, arteriovenous graft; FV-TCC, femoral vein tunneled cuffed catheter; NA, not available; LE-AVG, lower extremity arteriovenous graft; IJ-TCC, internal jugular tunneled cuffed catheter.